| GALVUS NOVARTIS AG 1990303 15 Oct 2019 | on 9 Feb 2022 | Pharmaceutical preparations for the prevention and treatment of the ce... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals. | |
| GALVUS MET NOVARTIS AG 1990302 15 Oct 2019 | on 9 Feb 2022 | Pharmaceutical preparations for the prevention and treatment of the ce... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals. | |
| GALVUSMET NOVARTIS AG 1565097 21 Feb 2012 | on 14 Mar 2018 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS & ISLET DESIGN NOVARTIS AG 1547239 11 Oct 2011 | on 29 Oct 2014 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS ISLET DESIGN NOVARTIS AG 1547243 11 Oct 2011 | on 29 Oct 2014 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS MET NOVARTIS AG 1547244 11 Oct 2011 | on 29 Oct 2014 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS MET & DESIGN NOVARTIS AG 1547245 11 Oct 2011 | on 29 Oct 2014 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS NOVARTIS AG 1547238 11 Oct 2011 | on 29 Oct 2014 | Pharmaceutical preparations for the prevention and/or treatment of the... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | |
| GALVUS MET & DESIGN NOVARTIS AG 1432168 24 Mar 2009 | on 16 Apr 2014 | Pharmaceutical preparations for the treatment of the central nervous s... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma or damage to the tissue or skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication. | |
| GALVUS MET NOVARTIS AG 1339132 13 Mar 2007 | on 2 Apr 2014 | Pharmaceutical preparations for the treatment of the central nervous s... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma or damage to the tissue or skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication. | |